Julia A Misplon Selected Research

Nucleoproteins

1/2022	Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies.
1/2021	Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice.
1/2018	Conventional influenza vaccines influence the performance of a universal influenza vaccine in mice.
1/2018	Reduction of influenza virus transmission from mice immunized against conserved viral antigens is influenced by route of immunization and choice of vaccine antigen.
1/2016	Age Dependence of Immunity Induced by a Candidate Universal Influenza Vaccine in Mice.
1/2013	Vaccination to conserved influenza antigens in mice using a novel Simian adenovirus vector, PanAd3, derived from the bonobo Pan paniscus.
11/2011	Intranasal administration of adeno-associated virus type 12 (AAV12) leads to transduction of the nasal epithelia and can initiate transgene-specific immune response.
11/2005	Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julia A Misplon Research Topics

Disease

18	Human Influenza (Influenza) 01/2022 - 08/2002
8	Infections 01/2022 - 08/2002
1	Weight Loss (Weight Reduction) 01/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019
1	Tetanus 01/2018
1	Diphtheria 01/2018

Drug/Important Bio-Agent (IBA)

11	VaccinesIBA 01/2022 - 03/2007
10	AntigensIBA 01/2022 - 08/2002
8	NucleoproteinsIBA 01/2022 - 11/2005
5	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022 - 06/2014
4	Proteins (Proteins, Gene)FDA Link 06/2014 - 08/2002
3	Neutralizing AntibodiesIBA 01/2022 - 08/2002
2	AntibodiesIBA 01/2022 - 11/2011
1	COVID-19 VaccinesIBA 12/2021
1	Diphtheria-Tetanus VaccineIBA 01/2018
1	ToxoidsIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Adenovirus VaccinesIBA 01/2011
1	A-Form DNA (A-DNA)IBA 03/2007
1	Influenza A virus M2 proteinIBA 03/2007
1	DNA VaccinesIBA 08/2002
1	Hemagglutinins (Hemagglutinin)IBA 08/2002